Combining Nurse Leader With Advocacy
Rate yourself using the results from the "Nurse Manager Skills Inventory":
http://www.aacn.org/wd/practice/docs/nurse-manager-inventory-tool.pdf
Write a reflection of 750-1,000 words in which you identify your strengths and weaknesses related to the four content areas below:
- Personal and professional accountability
- Career planning
- Personal journey disciplines
- Reflective practice reference behaviors/tenets
Discuss how you will use your current leadership skill set to advocate for change in your workplace.
Identify one personal goal for your leadership growth and discuss your implementation plan to achieve that goal.
While APA format is not required for the body of this assignment, solid academic writing is expected and in-text citations and references should be presented using APA documentation guidelines, which can be found in the APA Style Guide, located in the Student Success Center.
This assignment uses a rubric. Please review the rubric prior to beginning the assignment to become familiar with the expectations for successful completion.
10 years ago
20
Purchase the answer to view it

- advocacy_strategies.docx
- clinical_nurse_leaders.docx
Purchase the answer to view it

- ClinicalNurseLeaders.docx
Purchase the answer to view it

- combining_nurse_leader.docx
Purchase the answer to view it

- nrs_440v_week_5_combining_nurse_leader_with_advocacy.docx
Purchase the answer to view it

- combining_nurse_leader_with_advocacy.docx
- FOR PERFECTO Assignment 1
- Question
- As discussed
- Dr. Smith Harvey
- Week 9 Final assignment?
- Assignment 1 and 2 Elements: Business Assignment
- How can I maximize the potential of a racially and ethnically diverse workforce?
- just half page " response" for each one.
- Post a response to the following topic. Your analysis should be written in a paragraph format and should go beyond just repeating material presented in the course materials. Examine three tools, methods, or techniques that your organization or a company
- ACC 490 Week 3 DQ2

